{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:14:28Z","timestamp":1777594468070,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003646","name":"National Health Insurance Service","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009010","name":"Novartis Pharmaceuticals UK Limited","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["MR\/N003322\/1"],"award-info":[{"award-number":["MR\/N003322\/1"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K000608\/1"],"award-info":[{"award-number":["MR\/K000608\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Neurology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/s1474-4422(19)30200-5","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T18:30:35Z","timestamp":1565202635000},"page":"834-844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial"],"prefix":"10.1016","volume":"18","author":[{"given":"Michael G","family":"Hanna","sequence":"first","affiliation":[]},{"given":"Umesh A","family":"Badrising","sequence":"additional","affiliation":[]},{"given":"Olivier","family":"Benveniste","sequence":"additional","affiliation":[]},{"given":"Thomas E","family":"Lloyd","sequence":"additional","affiliation":[]},{"given":"Merrilee","family":"Needham","sequence":"additional","affiliation":[]},{"given":"Hector","family":"Chinoy","sequence":"additional","affiliation":[]},{"given":"Masashi","family":"Aoki","sequence":"additional","affiliation":[]},{"given":"Pedro M","family":"Machado","sequence":"additional","affiliation":[]},{"given":"Christina","family":"Liang","sequence":"additional","affiliation":[]},{"given":"Katrina A","family":"Reardon","sequence":"additional","affiliation":[]},{"given":"Marianne","family":"de Visser","sequence":"additional","affiliation":[]},{"given":"Dana P","family":"Ascherman","sequence":"additional","affiliation":[]},{"given":"Richard J","family":"Barohn","sequence":"additional","affiliation":[]},{"given":"Mazen M","family":"Dimachkie","sequence":"additional","affiliation":[]},{"given":"James A L","family":"Miller","sequence":"additional","affiliation":[]},{"given":"John T","family":"Kissel","sequence":"additional","affiliation":[]},{"given":"Bj\u00f6rn","family":"Oskarsson","sequence":"additional","affiliation":[]},{"given":"Nanette C","family":"Joyce","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Van den Bergh","sequence":"additional","affiliation":[]},{"given":"Jonathan","family":"Baets","sequence":"additional","affiliation":[]},{"given":"Jan L","family":"De Bleecker","sequence":"additional","affiliation":[]},{"given":"Chafic","family":"Karam","sequence":"additional","affiliation":[]},{"given":"William S","family":"David","sequence":"additional","affiliation":[]},{"given":"Massimiliano","family":"Mirabella","sequence":"additional","affiliation":[]},{"given":"Sharon P","family":"Nations","sequence":"additional","affiliation":[]},{"given":"Hans H","family":"Jung","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Pegoraro","sequence":"additional","affiliation":[]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[]},{"given":"Carmelo","family":"Rodolico","sequence":"additional","affiliation":[]},{"given":"Massimiliano","family":"Filosto","sequence":"additional","affiliation":[]},{"given":"Aziz I","family":"Shaibani","sequence":"additional","affiliation":[]},{"given":"Kumaraswamy","family":"Sivakumar","sequence":"additional","affiliation":[]},{"given":"Namita A","family":"Goyal","sequence":"additional","affiliation":[]},{"given":"Madoka","family":"Mori-Yoshimura","sequence":"additional","affiliation":[]},{"given":"Satoshi","family":"Yamashita","sequence":"additional","affiliation":[]},{"given":"Naoki","family":"Suzuki","sequence":"additional","affiliation":[]},{"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[]},{"given":"Kenya","family":"Murata","sequence":"additional","affiliation":[]},{"given":"Hiroyuki","family":"Nodera","sequence":"additional","affiliation":[]},{"given":"Ichizo","family":"Nishino","sequence":"additional","affiliation":[]},{"given":"Carla D","family":"Romano","sequence":"additional","affiliation":[]},{"given":"Valerie S L","family":"Williams","sequence":"additional","affiliation":[]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[]},{"given":"Lixin Zhang","family":"Auberson","sequence":"additional","affiliation":[]},{"given":"Min","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Ana","family":"de Vera","sequence":"additional","affiliation":[]},{"given":"Dimitris A","family":"Papanicolaou","sequence":"additional","affiliation":[]},{"given":"Anthony A","family":"Amato","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S1474-4422(19)30200-5_bib1","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/brain\/awr213","article-title":"Long-term observational study of sporadic inclusion body myositis","volume":"134","author":"Benveniste","year":"2011","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(19)30200-5_bib2","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/brain\/awr217","article-title":"A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities","volume":"134","author":"Cox","year":"2011","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(19)30200-5_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nmd.2013.02.010","article-title":"Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials","volume":"23","author":"Cortese","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/S1474-4422(19)30200-5_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JND-160198","article-title":"A systematic review and meta-analysis of prevalence studies of sporadic inclusion body myositis","volume":"4","author":"Callan","year":"2017","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/S1474-4422(19)30200-5_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ncl.2014.04.001","article-title":"Inclusion body myositis","volume":"32","author":"Dimachkie","year":"2014","journal-title":"Neurol Clin"},{"key":"10.1016\/S1474-4422(19)30200-5_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/JND-150138","article-title":"Mortality and causes of death in patients with sporadic inclusion body myositis: survey study based on the clinical experience of specialists in Australia, Europe and the USA","volume":"3","author":"Price","year":"2016","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/S1474-4422(19)30200-5_bib7","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2147\/TCRM.S65368","article-title":"Emerging therapeutic options for sporadic inclusion body myositis","volume":"11","author":"Alfano","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/S1474-4422(19)30200-5_bib8","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/BOR.0000000000000436","article-title":"Inclusion body myositis: advancements in diagnosis, pathomechanisms, and treatment","volume":"29","author":"Schmidt","year":"2017","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/S1474-4422(19)30200-5_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11926-018-0755-z","article-title":"Update on inclusion body myositis","volume":"20","author":"Jabari","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/S1474-4422(19)30200-5_bib10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s13311-018-0658-8","article-title":"Inclusion body myositis: update on pathogenesis and treatment","volume":"15","author":"Naddaf","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/S1474-4422(19)30200-5_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","article-title":"Inclusion body myositis: clinical features and pathogenesis","volume":"15","author":"Greenberg","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/S1474-4422(19)30200-5_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neurol.2016.07.016","article-title":"Sporadic inclusion-body myositis: recent advances and the state of the art in 2016","volume":"172","author":"Gallay","year":"2016","journal-title":"Rev Neurol"},{"key":"10.1016\/S1474-4422(19)30200-5_bib13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/mus.25036","article-title":"A protocol to develop clinical guidelines for inclusion-body myositis","volume":"53","author":"Jones","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/S1474-4422(19)30200-5_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2174\/138920207783591672","article-title":"Myostatin in the pathophysiology of skeletal muscle","volume":"8","author":"Carnac","year":"2007","journal-title":"Curr Genomics"},{"key":"10.1016\/S1474-4422(19)30200-5_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0838.2007.00759.x","article-title":"Myostatin inhibition: a potential performance enhancement strategy?","volume":"18","author":"Fedoruk","year":"2008","journal-title":"Scand J Med Sci Sports"},{"key":"10.1016\/S1474-4422(19)30200-5_bib16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/MCB.01307-13","article-title":"An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy","volume":"34","author":"Lach-Trifilieff","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S1474-4422(19)30200-5_bib17","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/SPC.0000000000000013","article-title":"Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders","volume":"7","author":"Smith","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/S1474-4422(19)30200-5_bib18","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1212\/WNL.0000000000001070","article-title":"Treatment of sporadic inclusion body myositis with bimagrumab","volume":"83","author":"Amato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/S1474-4422(19)30200-5_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.nmd.2009.11.003","article-title":"Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008","volume":"20","author":"Hilton-Jones","year":"2010","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/S1474-4422(19)30200-5_bib20","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1093\/brain\/awr258","article-title":"Update on sporadic inclusion body myositis","volume":"134","author":"Hohlfeld","year":"2011","journal-title":"Brain"},{"key":"10.1016\/S1474-4422(19)30200-5_bib21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/mus.25373","article-title":"Modeling functional decline over time in sporadic inclusion body myositis","volume":"55","author":"Alfano","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/S1474-4422(19)30200-5_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/mus.25079","article-title":"Development of the sporadic inclusion body myositis physical functioning assessment (sIFA)","volume":"54","author":"DeMuro","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/S1474-4422(19)30200-5_bib24","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/mus.25080","article-title":"Psychometric validation of a patient-reported measure of physical functioning in sporadic inclusion body myositis","volume":"54","author":"Williams","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/S1474-4422(19)30200-5_bib25","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/sim.3495","article-title":"A graphical approach to sequentially rejective multiple test procedures","volume":"28","author":"Bretz","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/S1474-4422(19)30200-5_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"Guidelines for the 6-minute walk test","volume":"166","year":"2002","journal-title":"Am J Resp Crit Care Med"},{"key":"10.1016\/S1474-4422(19)30200-5_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1378\/chest.123.2.387","article-title":"The 6-min walk test: a quick measure of functional status in elderly adults","volume":"123","author":"Enright","year":"2003","journal-title":"Chest"}],"container-title":["The Lancet Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442219302005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1474442219302005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T10:20:16Z","timestamp":1761474016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1474442219302005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1474442219302005"],"URL":"https:\/\/doi.org\/10.1016\/s1474-4422(19)30200-5","relation":{},"ISSN":["1474-4422"],"issn-type":[{"value":"1474-4422","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(19)30200-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(19)30279-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}